Association of thyroid-stimulating hormone with corrected QT interval variation: A prospective cohort study among patients with type 2 diabetes

Background. - Patients with type 2 diabetes mellitus (T2DM) have a prolonged QT interval and are at high risk of sudden cardiac death. A prolonged QT interval, indicative of impaired ventricular repolarization, is a risk factor for lethal ventricular arrhythmias, such as torsadesde-pointes (TdP). Aims. - To identify key clinical and biochemical covariates associated with Fridericia's corrected QT interval (QTcF) among euthyroid patients with T2DM, and to describe the temporal relationship between these factors and QTcF. Methods. - We performed prospective, clinical, biochemical and electrocardiographic measurements among patients with T2DM enrolled in the DIACART study at Pitie-Salpetriere Hospital, at T1 (baseline) and T2 (follow-up), with a median interval of 2.55 years. Results. - Mean age (63.9 +/- 8.5 years), sex (22.35% women), drugs with known risk of TdP according to the CredibleMeds website (Cred-drugsTdP) and serum thyroid-stimulating hormone (TSH) concentrations correlated with QTcF in univariate analysis at both T1 and T2. In multivariable analysis, all these covariates except age were significantly associated with QTcF at both T1 (women: standardized 8 = 0.24 +/- 0.07, P = 0.001; Cred-drugsTdP: 8 = 0.19 +/- 0.07, P = 0.007; TSH concentration: 8 = 0.18 +/- 0.07, P = 0.01) and T2 (women: 8 = 0.25 +/- 0.08, P = 0.002; CreddrugsTdP: 8 = 0.25 +/- 0.08, P = 0.001; TSH concentration: 8 = 0.19 +/- 0.08, P = 0.01). Furthermore, variation in QTcF over the years was associated with variation in TSH concentration (r = 0.24, P = 0.007) and changes in use of Cred-drugsTdP (r = 0.2, P = 0.02). Conclusions. - Serum TSH concentration and its variation were associated with QTcF and its variation, even after correcting for the main determinants of QTcF. Interventional optimization of TSH concentration in T2DM warrants further investigation to establish its impact on the risk of TdP and sudden cardiac death. (C) 2021 Elsevier Masson SAS. All rights reserved.